Clinical trial
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
NCT00529581
Study timeline
Study start (unknown)2006-11-01Date precision: month
Registry last updated2008-05-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cognition Disordersunresolved
Multiple Sclerosisunresolved
Interventions
C105DRUG
Sponsors & collaborators
Cognition Pharmaceuticals, LLClead sponsor
Mapped research locations
SarasotaFlorida, United States2HoustonTexas, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1CincinnatiOhio, United States1TampaFlorida, United States1PhoenixArizona, United States1DetroitMichigan, United States1New HavenConnecticut, United States1RichmondVirginia, United States1LexingtonKentucky, United States1BuffaloNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00529581 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.